|
|
Maternal mediators of fetal growth restriction linked to prenatal alcohol exposure |
| 1R01AA029594-01A1 |
|
NIAAA |
2022 |
|
|
Cardiovascular disease in fetal alcohol spectrum disorder |
| 1U01AA030185-01 |
|
NIAAA |
2022 |
|
|
Project 2: Prenatal Alcohol Exposure (PAE) and Fetal Alcohol Spectrum Disorder (FASD) |
| 1U54AA030451-01 |
|
NIAAA |
2022 |
|
|
Prenatal Alcohol Exposure and Fetal Alcohol Spectrum Disorder |
| 1U54AA030463-01 |
|
NIAAA |
2022 |
|
|
Prenatal Alcohol and Neuroimmunity |
| 5R01AA022460-08 |
|
NIAAA |
2022 |
|
|
Fetal alcohol exposure: effects on immunity of the premature newborn |
| 5R01AA027020-04 |
|
NIAAA |
2022 |
|
|
Project 4: Whole-brain and body characterization of sleep disturbances and interventions in Fmr1, Shank3 and Cntnap2 knockout zebrafish |
| 1P50HD109861-01 |
|
NICHD |
2022 |
|
|
Cellular plasticity and lineage in mammalian digit tip regeneration |
| 1R01HD109200-01 |
|
NICHD |
2022 |
|
|
Placental Organoids for Modeling and Treating Preeclampsia |
| 1R21HD108867-01 |
|
NICHD |
2022 |
|
|
The development and evaluation of a novel Cat Assisted Training (CAT) intervention for youth with developmental disabilities and their family cat |
| 1R21HD109853-01 |
|
NICHD |
2022 |